BIOMAT Database Logo BIOMAT Database Logo

[Effectiveness of prodigiozan in the complex treatment of erysipelas]. 1984

V M Frolov, and V E Rychnev

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D011354 Prodigiozan A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes. Prodigiosan
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004886 Erysipelas An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V M Frolov, and V E Rychnev
[Effectiveness of thymalin and prodigiozan in the complex treatment of patients with dysentery].
July 1985, Voenno-meditsinskii zhurnal,
V M Frolov, and V E Rychnev
[Prodigiozan in the complex treatment of respiratory tract sarcoidosis].
September 1982, Klinicheskaia meditsina,
V M Frolov, and V E Rychnev
[Use of prodigiozan in complex treatment of endogenous infections].
January 1980, Terapevticheskii arkhiv,
V M Frolov, and V E Rychnev
[Effectiveness of levamisole, prodigiozan and diucifon in the treatment of acute pneumonia].
January 1983, Terapevticheskii arkhiv,
V M Frolov, and V E Rychnev
[Complex treatment of erysipelas in a surgical clinic].
June 1986, Vestnik khirurgii imeni I. I. Grekova,
V M Frolov, and V E Rychnev
[On the therapeutic effectiveness of prodigiozan in chronic colitis].
November 1968, Antibiotiki,
V M Frolov, and V E Rychnev
[Use of pyrogenal in a complex treatment of erysipelas].
February 1973, Sovetskaia meditsina,
V M Frolov, and V E Rychnev
[Use of prodigiozan in the complex therapy of dysentery].
April 1973, Vrachebnoe delo,
V M Frolov, and V E Rychnev
[Use of prodigiozan in the complex therapy of burns].
January 1971, Antibiotiki,
V M Frolov, and V E Rychnev
[Complex methods of treatment and prevention of erysipelas].
June 1976, Klinicheskaia meditsina,
Copied contents to your clipboard!